Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-142137

Chief Financial Officer sold 5,727 shares at $18.64 ($106,751)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lucera Erick · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-01 Sale : show line 1 in the form 10b5-1 −5,727 $18.64 $106,751 125,373 D
Open-market sales · 5,727 sh · avg $18.64 · $106,751
Loading xslF345X06/ownership.xml…